Atypical E2Fs inhibit tumor angiogenesis

Autor: Bart Westendorp, Stefan Schulte-Merker, M Zijp, W J Bakker, B T Hien, Bart Weijts, Rachel E. Thomas, L M Martínez-López, A. de Bruin, Ingrid Thurlings
Přispěvatelé: CCA - Cancer biology and immunology, Dermatology, Medical Biology, LS Pathobiologie, dPB RMSC
Jazyk: angličtina
Rok vydání: 2018
Předmět:
0301 basic medicine
Keratinocytes
Cancer Research
Angiogenesis
HYPOXIA
CELL-MIGRATION
Neovascularization
ACTIVATION
Mice
E2F7 Transcription Factor
Neoplasms
VASCULATURE
TRANSCRIPTION
NETWORK
Zebrafish
IN-VIVO
Regulation of gene expression
Mice
Knockout

Neovascularization
Pathologic

Intracellular Signaling Peptides and Proteins
PROLIFERATION
Cell migration
CANCER
APOPTOSIS
Gene Expression Regulation
Neoplastic

medicine.anatomical_structure
medicine.symptom
Blood vessel
Short Communication
Primary Cell Culture
Mice
Nude

Biology
03 medical and health sciences
Cell Line
Tumor

medicine
Genetics
Animals
Humans
Molecular Biology
Adaptor Proteins
Signal Transducing

Calcium-Binding Proteins
Membrane Proteins
Neoplasms
Experimental

Fibroblasts
biology.organism_classification
Xenograft Model Antitumor Assays
Repressor Proteins
030104 developmental biology
Apoptosis
Cell culture
Cancer research
Carcinogens
Zdroj: Oncogene, 37, 271. Nature Publishing Group
ONCOGENE, 37(2), 271-276. Nature Publishing Group
Oncogene, 37(2), 271-276. Nature Publishing Group
Oncogene, 37(2), 271. Nature Publishing Group
Oncogene
ISSN: 0950-9232
Popis: Atypical E2F transcription factors (E2F7 and E2F8) function as key regulators of cell cycle progression and their inactivation leads to spontaneous cancer formation in mice. However, the mechanism of the tumor suppressor functions of E2F7/8 remain obscure. In this study we discovered that atypical E2Fs control tumor angiogenesis, one of the hallmarks of cancer. We genetically inactivated atypical E2Fs in epithelial and mesenchymal neoplasm and analyzed blood vessel formation in three different animal models of cancer. Tumor formation was either induced by application of 7,12-Dimethylbenz(a)anthracene/12-O-Tetradecanoylphorbol-13-acetate or by Myc/Ras overexpression. To our surprise, atypical E2Fs suppressed tumor angiogenesis in all three cancer models, which is in a sharp contrast to previous findings showing that atypical E2Fs promote angiogenesis during fetal development in mice and zebrafish. Real-time imaging in zebrafish displayed that fluorescent-labeled blood vessels showed enhanced intratumoral branching in xenografted E2f7/8-deficient neoplasms compared with E2f7/8-proficient neoplasms. DLL4 expression, a key negative inhibitor of vascular branching, was decreased in E2f7/8-deficient neoplastic cells, indicating that E2F7/8 might inhibit intratumoral vessel branching via induction of DLL4.Oncogene advance online publication, 18 September 2017; doi:10.1038/onc.2017.336.
Databáze: OpenAIRE